Vaxart Past Performance
How has Vaxart performed over the past 5 years?
Past Performance Score
0/6Past Performance Score 0/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
-46.1%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: VXRT is currently unprofitable.
Growing Profit Margin: VXRT is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: VXRT is unprofitable, and losses have increased over the past 5 years at a rate of 46.1% per year.
Accelerating Growth: Unable to compare VXRT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VXRT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (53%).
Return on Equity
High ROE: VXRT has a negative Return on Equity (-85.53%), as it is currently unprofitable.